Sunrise™ in Mongolia
22 November 2011 | By kdm communications limited
Donation of a Tecan Sunrise™ microplate reader to Mongolian medical researchers, assisting their studies of vitamin D levels in the general population...
List view / Grid view
News
Merck resolves previously disclosed seven-year investigation
22 November 2011 | By Merck
Merck has reached a resolution with federal and state authorities regarding a previously disclosed investigation concerning Vioxx...
Pfizer and MIT break ground on new research units in Kendall Square
21 November 2011 | By Pfizer
10-year lease marks a strategic partnership between the academic research community and industry to boost innovation...
Gilead Sciences to acquire Pharmasset, Inc. for $11 billion
21 November 2011 | By Gilead Sciences
Gilead Sciences, Inc., will acquire Pharmasset, Inc., for $137 per share in cash...
Abbott introduces the first FDA-approved supplemental blood test for Chagas disease
21 November 2011 | By Abbott
Abbott received approval from the U.S. FDA for a new Chagas in vitro diagnostic test...
Pfizer announces EMA acceptance of regulatory submission for Tofacitinib for the treatment of Rheumatoid Arthritis
21 November 2011 | By Pfizer
Pfizer Inc. announced that its Market Authorisation Application for tofacitinib...
FDA Commissioner announces final decision on Avastin for metastatic breast cancer
18 November 2011 | By Roche
FDA Commissioner revokes approval of Avastin for treatment of mBC in the US...
CAPRELSA™ (vandetanib) receives positive CHMP opinion in the European Union for treating advanced medullary thyroid cancer
18 November 2011 | By AstraZeneca
CAPRELSA receives a positive opinion...
GlaxoSmithKline welcomes innovative knowledge-sharing collaboration to break deadlock in antibiotic discovery and development
17 November 2011 | By GlaxoSmithKline
GSK welcomes the EC’s commitment...
GSK welcomes GAVI Alliance decision to introduce vaccines against cervical cancer and rubella in the world’s poorest countries
17 November 2011 | By GlaxoSmithKline
GSK welcomed the decision of the GAVI...
Lilly provides additional funding to Infectious Disease Research Institute to identify new Tuberculosis therapies
17 November 2011 | By Eli Lilly and Company
Eli Lilly and Company is providing more than $4 million in additional funding...
4th Tecan Symposium enjoys Chinese success
17 November 2011 | By kdm communications limited
The fourth annual Tecan Symposium, welcomed leading genomics, proteomics & biobanking experts from around the globe...
Novartis and collaborators discover new dual-acting class of antimalarial compounds with potential to both prevent and treat malaria infections
17 November 2011 | By Novartis
Discovery of a new class of dual-acting antimalarial compounds...
GSK receives initial data from the first completed phase lll study of albiglutide in type 2 diabetes
16 November 2011 | By GlaxoSmithKline
GlaxoSmithKline announced that topline results have been received...
Syrris sponsor 1st Flow Chemistry Symposium in Brazil
16 November 2011 | By kdm communications limited
Syrris, is pleased to be a sponsor of the 1st Flow Chemistry Symposium (1st FCS)...
